{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:57:53Z","timestamp":1772585873182,"version":"3.50.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-02158-x","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T09:35:42Z","timestamp":1769247342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of mineral supplements (magnesium, chromium, zinc, selenium, chromium picolinate) in reducing insulin resistance in polycystic ovary syndrome: a meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiahui","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoxia","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cancan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gong","family":"Yaping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"4","key":"2158_CR1","first-page":"1049","volume":"55","author":"G Huihui","year":"2024","unstructured":"Huihui G, Beiran Q, Yan N, Liying S, Junfen F. Research progress in the pathogenesis of polycystic ovary syndrome. J Sichuan Univ (Medical Sciences). 2024;55(4):1049\u201354.","journal-title":"J SICHUAN Univ (MEDICAL SCIENCES)"},{"issue":"4","key":"2158_CR2","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/humrep\/deaa371","volume":"36","author":"J Liu","year":"2021","unstructured":"Liu J, Wu Q, Hao Y, Jiao M, Wang X, Jiang S, Han L. Measuring the global disease burden of polycystic ovary syndrome in 194 countries: global burden of disease study 2017. Hum Reprod. 2021;36(4):1108\u201319.","journal-title":"Hum Reprod"},{"key":"2158_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27\u201336.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"2158_CR4","doi-asserted-by":"publisher","first-page":"2430878","DOI":"10.1080\/20565623.2024.2430878","volume":"10","author":"RF Begum","year":"2024","unstructured":"Begum RF, Vellapandian C, Mohan S. Examining symptom and quality of life in polycystic ovarian syndrome: a web-based cross-sectional study. Future Sci OA. 2024;10(1):2430878.","journal-title":"Future Sci OA"},{"key":"2158_CR5","doi-asserted-by":"publisher","first-page":"960965","DOI":"10.3389\/fpubh.2022.960965","volume":"10","author":"T Chen","year":"2022","unstructured":"Chen T, Yu Y, Jia F, Luan P, Liu X. The relationship between polycystic ovary syndrome and insulin resistance from 1983 to 2022: A bibliometric analysis. Front Public Health. 2022;10:960965.","journal-title":"Front Public Health"},{"key":"2158_CR6","doi-asserted-by":"publisher","first-page":"1358755","DOI":"10.3389\/fcell.2024.1358755","volume":"12","author":"A Joshi","year":"2024","unstructured":"Joshi A. PCOS stratification for precision diagnostics and treatment. Front Cell Dev Biol. 2024;12:1358755.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"2158_CR7","doi-asserted-by":"publisher","first-page":"e0153196","DOI":"10.1371\/journal.pone.0153196","volume":"11","author":"Y Guo","year":"2016","unstructured":"Guo Y, Qi Y, Yang X, Zhao L, Wen S, Liu Y, Tang L. Association between polycystic ovary syndrome and gut microbiota. PLoS ONE. 2016;11(4):e0153196.","journal-title":"PLoS ONE"},{"issue":"6","key":"2158_CR8","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1096\/fj.201802653RR","volume":"33","author":"Y Arao","year":"2019","unstructured":"Arao Y, Hamilton KJ, Wu S-P, Tsai M-J, DeMayo FJ, Korach KS. Dysregulation of hypothalamic-pituitary Estrogen receptor \u03b1\u2013mediated signaling causes episodic LH secretion and cystic ovary. FASEB J. 2019;33(6):7375.","journal-title":"FASEB J"},{"key":"2158_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","volume":"86","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism. 2018;86:33\u201343.","journal-title":"Metabolism"},{"issue":"4","key":"2158_CR10","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.3390\/ijms24043140","volume":"24","author":"R Herman","year":"2023","unstructured":"Herman R, Sikonja J, Jensterle M, Janez A, Dolzan V. Insulin metabolism in polycystic ovary syndrome: secretion, signaling, and clearance. Int J Mol Sci. 2023;24(4):3140.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2158_CR11","first-page":"1","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nat Reviews Disease Primers. 2016;2(1):1\u201318.","journal-title":"Nat Reviews Disease Primers"},{"key":"2158_CR12","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.2147\/IJWH.S514423","volume":"17","author":"EJ Callander","year":"2025","unstructured":"Callander EJ, Hu Y, Carrandi A, Tay CT, Mousa A, Teede H. Cost-Effectiveness of interventions related to the treatment of women with polycystic ovary syndrome: A scoping review. Int J Womens Health. 2025;17:1333\u201341.","journal-title":"Int J Womens Health"},{"issue":"2","key":"2158_CR13","doi-asserted-by":"publisher","first-page":"E173","DOI":"10.1152\/ajpendo.00287.2021","volume":"322","author":"LA Jahn","year":"2022","unstructured":"Jahn LA, Hartline L, Liu Z, Barrett EJ. Metformin improves skeletal muscle microvascular insulin resistance in metabolic syndrome. Am J Physiology-Endocrinology Metabolism. 2022;322(2):E173\u201380.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"2158_CR14","doi-asserted-by":"crossref","unstructured":"Attia GM, Almouteri MM, Alnakhli FT, Almouteri M, Alnakhli F. Role of metformin in polycystic ovary syndrome (PCOS)-related infertility. Cureus 2023;15(8):e44493.","DOI":"10.7759\/cureus.44493"},{"issue":"1","key":"2158_CR15","first-page":"85","volume":"27","author":"A Manouchehri","year":"2023","unstructured":"Manouchehri A, Abbaszadeh S, Ahmadi M, Nejad FK, Bahmani M, Dastyar N. Polycystic ovaries and herbal remedies: a systematic review. JBRA Assist Reprod. 2023;27(1):85\u201391.","journal-title":"JBRA Assist Reprod"},{"issue":"2 Suppl 3","key":"2158_CR16","first-page":"E206","volume":"63","author":"AK Kiani","year":"2022","unstructured":"Kiani AK, Donato K, Dhuli K, Stuppia L, Bertelli M. Dietary supplements for polycystic ovary syndrome. J Prev Med Hyg. 2022;63(2 Suppl 3):E206\u201313.","journal-title":"J Prev Med Hyg"},{"issue":"7","key":"2158_CR17","doi-asserted-by":"publisher","first-page":"e14117","DOI":"10.1111\/jfbc.14117","volume":"46","author":"R Shahid","year":"2022","unstructured":"Shahid R, Mahnoor, Awan KA, Iqbal MJ, Munir H, Saeed I. Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS). J Food Biochem. 2022;46(7):e14117.","journal-title":"J Food Biochem"},{"issue":"4","key":"2158_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/metabo12040338","volume":"12","author":"T ElObeid","year":"2022","unstructured":"ElObeid T, Awad MO, Ganji V, Moawad J. The impact of mineral supplementation on polycystic ovarian syndrome. Metabolites. 2022;12(4):338.","journal-title":"Metabolites"},{"issue":"6","key":"2158_CR19","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/ijo.2010.14","volume":"34","author":"Y Li","year":"2010","unstructured":"Li Y, Wang C, Zhu K, Feng R, Sun C. Effects of multivitamin and mineral supplementation on adiposity, energy expenditure and lipid profiles in obese Chinese women. Int J Obes. 2010;34(6):1070\u201377.","journal-title":"Int J Obes"},{"issue":"1","key":"2158_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11684-013-0251-9","volume":"7","author":"X Miao","year":"2013","unstructured":"Miao X, Sun W, Fu Y, Miao L, Cai L. Zinc homeostasis in the metabolic syndrome and diabetes. Front Med. 2013;7(1):31\u201352.","journal-title":"Front Med"},{"key":"2158_CR21","doi-asserted-by":"publisher","first-page":"106647","DOI":"10.1016\/j.phrs.2023.106647","volume":"188","author":"J Xia","year":"2023","unstructured":"Xia J, Yu J, Xu H, Zhou Y, Li H, Yin S, Xu D, Wang Y, Xia H, Liao W. Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review and network meta-analysis of randomized controlled trials. Pharmacol Res. 2023;188:106647.","journal-title":"Pharmacol Res"},{"issue":"8","key":"2158_CR22","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jnutbio.2005.10.006","volume":"17","author":"AS Mueller","year":"2006","unstructured":"Mueller AS, Pallauf J. Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db\/db mice. J Nutr Biochem. 2006;17(8):548\u201360.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"2158_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12011-017-1236-3","volume":"185","author":"M Jamilian","year":"2018","unstructured":"Jamilian M, Zadeh Modarres S, Amiri Siavashani M, Karimi M, Mafi A, Ostadmohammadi V, Asemi Z. The influences of chromium supplementation on glycemic control, markers of cardio-metabolic risk, and oxidative stress in infertile polycystic ovary syndrome women candidate for in vitro fertilization: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res. 2018;185(1):48\u201355.","journal-title":"Biol Trace Elem Res"},{"key":"2158_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2018.04.003","volume":"56","author":"V Maleki","year":"2018","unstructured":"Maleki V, Izadi A, Farsad-Naeimi A, Alizadeh M. Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review. Nutr Res. 2018;56:1\u201310.","journal-title":"Nutr Res"},{"issue":"3","key":"2158_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.mefs.2017.11.003","volume":"23","author":"M Kanafchian","year":"2018","unstructured":"Kanafchian M, Mahjoub S, Esmaeilzadeh S, Rahsepar M, Mosapour A. Status of serum selenium and zinc in patients with the polycystic ovary syndrome with and without insulin resistance. Middle East Fertility Soc J. 2018;23(3):241\u201345.","journal-title":"Middle East Fertility Soc J"},{"key":"2158_CR26","doi-asserted-by":"publisher","first-page":"S429","DOI":"10.1016\/j.dsx.2017.03.030","volume":"11","author":"Z Faghfoori","year":"2017","unstructured":"Faghfoori Z, Fazelian S, Shadnoush M, Goodarzi R. Nutritional management in women with polycystic ovary syndrome: A review study. Diabetes Metabolic Syndrome: Clin Res Reviews. 2017;11:S429\u201332.","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"issue":"8","key":"2158_CR27","first-page":"501578","volume":"72","author":"M Hamsho","year":"2025","unstructured":"Hamsho M, Ranneh Y, Fadel A. Therapeutic effects of chromium supplementation on women with polycystic ovarian syndrome: A systematic review and meta-analysis. Endocrinol Diabetes Nutr (Engl Ed). 2025;72(8):501578.","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"2158_CR28","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372.","DOI":"10.1136\/bmj.n71"},{"issue":"1","key":"2158_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"TR ESHRE","year":"2004","unstructured":"ESHRE TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"issue":"1002","key":"2158_CR30","first-page":"14651858","volume":"4","author":"J Chandler","year":"2019","unstructured":"Chandler J, Cumpston M, Li T, Page MJ, Welch V. Cochrane handbook for systematic reviews of interventions. Hoboken: Wiley. 2019;4(1002):14651858.","journal-title":"Hoboken: Wiley"},{"issue":"7650","key":"2158_CR31","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u201326.","journal-title":"BMJ"},{"issue":"3","key":"2158_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1037\/h0045186","volume":"65","author":"J Cohen","year":"1962","unstructured":"Cohen J. The statistical power of abnormal-social psychological research: a review. J Abnorm Social Psychol. 1962;65(3):145.","journal-title":"J Abnorm Social Psychol"},{"key":"2158_CR33","doi-asserted-by":"crossref","unstructured":"Deeks JJ, Higgins JP, Altman DG, Group CSM. Analysing data and undertaking meta-analyses. Cochrane Handb Syst Reviews Interventions 2019:241\u201384.","DOI":"10.1002\/9781119536604.ch10"},{"key":"2158_CR34","doi-asserted-by":"crossref","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994:1088\u20131101.","DOI":"10.2307\/2533446"},{"key":"2158_CR35","doi-asserted-by":"crossref","unstructured":"Sterne J, Egger M, Smith G. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ [Internet]. 2001 Jul 14 [cited 2015 Jul 28];323(7304):101\u20135.","DOI":"10.1136\/bmj.323.7304.101"},{"issue":"3","key":"2158_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/jog.12907","volume":"42","author":"S Ashoush","year":"2016","unstructured":"Ashoush S, Abou-Gamrah A, Bayoumy H, Othman N. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: randomized controlled trial. J Obstet Gynecol Res. 2016;42(3):279\u201385.","journal-title":"J Obstet Gynecol Res"},{"issue":"1","key":"2158_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000438465","volume":"67","author":"M Jamilian","year":"2015","unstructured":"Jamilian M, Asemi Z. Chromium supplementation and the effects on metabolic status in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Annals Nutr Metabolism. 2015;67(1):42\u20138.","journal-title":"Annals Nutr Metabolism"},{"issue":"04","key":"2158_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-0035-1548790","volume":"123","author":"F Foroozanfard","year":"2015","unstructured":"Foroozanfard F, Jamilian M, Jafari Z, Khassaf A, Hosseini A, Khorammian H, Asemi Z. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes. 2015;123(04):215\u201320.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"2158_CR39","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/cen.12699","volume":"82","author":"M Jamilian","year":"2015","unstructured":"Jamilian M, Razavi M, Fakhrie Kashan Z, Ghandi Y, Bagherian T, Asemi Z. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2015;82(6):885\u201391.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2158_CR40","unstructured":"Jamilian M, Maktabi M, Asemi Z. A trial on the effects of magnesium-zinc-calcium-vitamin D co-supplementation on glycemic control and markers of cardio-metabolic risk in women with polycystic ovary syndrome. Arch Iran Med. 2017;20(10) :640\u201345."},{"key":"2158_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.clnesp.2022.07.017","volume":"51","author":"S Zadeh Modarres","year":"2022","unstructured":"Zadeh Modarres S, Asemi Z, Heidar Z. The effects of selenium supplementation on glycemic control, serum lipoproteins and biomarkers of oxidative stress in infertile women diagnosed with polycystic ovary syndrome undergoing in vitro fertilization: A randomized, double-blind, placebo-controlled trial. Clin Nutr ESPEN. 2022;51:92\u20136.","journal-title":"Clin Nutr ESPEN"},{"issue":"2","key":"2158_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12011-019-01923-z","volume":"196","author":"M Farsinejad-Marj","year":"2020","unstructured":"Farsinejad-Marj M, Azadbakht L, Mardanian F, Saneei P, Esmaillzadeh A. Clinical and metabolic responses to magnesium supplementation in women with polycystic ovary syndrome. Biol Trace Elem Res. 2020;196(2):349\u201358.","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"2158_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12011-019-01720-8","volume":"193","author":"M Jamilian","year":"2020","unstructured":"Jamilian M, Foroozanfard F, Kavossian E, Kia M, Aghadavod E, Amirani E, Asemi Z. Effects of chromium and carnitine co-supplementation on body weight and metabolic profiles in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res. 2020;193(2):334\u201341.","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"2158_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s12011-023-03744-7","volume":"202","author":"S Shahmoradi","year":"2023","unstructured":"Shahmoradi S, Chiti H, Tavakolizadeh M, Hatami R, Motamed N, Ghaemi M. The effect of magnesium supplementation on insulin resistance and metabolic profiles in women with polycystic ovary syndrome: a randomized clinical trial. Biol Trace Elem Res. 2023;202(3):941\u201346.","journal-title":"Biol Trace Elem Res"},{"key":"2158_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jtemb.2016.01.002","volume":"34","author":"F Mohammad Hosseinzadeh","year":"2016","unstructured":"Mohammad Hosseinzadeh F, Hosseinzadeh-Attar MJ, Yekaninejad MS, Rashidi B. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial. J Trace Elem Med Biol. 2016;34:56\u201361.","journal-title":"J Trace Elem Med Biol"},{"issue":"3","key":"2158_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4239\/wjd.v13.i3.129","volume":"13","author":"CA Amisi","year":"2022","unstructured":"Amisi CA. Markers of insulin resistance in polycystic ovary syndrome women: an update. World J Diabetes. 2022;13(3):129\u201349.","journal-title":"World J Diabetes"},{"issue":"1","key":"2158_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023;16(1):9.","journal-title":"J Ovarian Res"},{"issue":"8","key":"2158_CR48","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, Rizka A, Tarigan TJE, Harbuwono DS, Purnamasari D, et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and Tryglyceride\/glucose index. Diabetes Metab Syndr. 2022;16(8):102581.","journal-title":"Diabetes Metab Syndr"},{"issue":"19","key":"2158_CR49","doi-asserted-by":"publisher","first-page":"e14607","DOI":"10.14814\/phy2.14607","volume":"8","author":"SC da Silva Rosa","year":"2020","unstructured":"da Silva Rosa SC, Nayak N, Caymo AM, Gordon JW. Mechanisms of muscle insulin resistance and the cross-talk with liver and adipose tissue. Physiol Rep. 2020;8(19):e14607.","journal-title":"Physiol Rep"},{"issue":"1","key":"2158_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13048-020-00670-3","volume":"13","author":"F-F He","year":"2020","unstructured":"He F-F, Li Y-M. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res. 2020;13(1):73.","journal-title":"J Ovarian Res"},{"issue":"7","key":"2158_CR51","doi-asserted-by":"publisher","first-page":"9563","DOI":"10.1096\/fj.202000605RR","volume":"34","author":"C Zhang","year":"2020","unstructured":"Zhang C, Hu J, Wang W, Sun Y, Sun K. HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS. FASEB J. 2020;34(7):9563\u201374.","journal-title":"FASEB J"},{"key":"2158_CR52","doi-asserted-by":"crossref","unstructured":"Kruszewska J, Laudy-Wiaderny H, Kunicki M. Review of novel potential insulin resistance biomarkers in PCOS patients-The debate is still open. Int J Environ Res Public Health 2022;19(4):2099.","DOI":"10.3390\/ijerph19042099"},{"issue":"26","key":"2158_CR53","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.2174\/138161209789058101","volume":"15","author":"AB Motta","year":"2009","unstructured":"Motta AB. Mechanisms involved in Metformin action in the treatment of polycystic ovary syndrome. Curr Pharm Des. 2009;15(26):3074\u201377.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"2158_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.numecd.2021.09.029","volume":"32","author":"M Rahimlou","year":"2021","unstructured":"Rahimlou M, Grau N, Banaie-Jahromi N, Taheri M, Khosravi A, Mavrommatis Y, Mohammadifard N. Association of adherence to the dietary approach to stop hypertension and mediterranean diets with blood pressure in a non-hypertensive population: results from Isfahan salt study (ISS). Nutr Metab Cardiovasc Dis. 2021;32(1):109\u201316.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2158_CR55","doi-asserted-by":"crossref","unstructured":"Nasiadek M, Stragierowicz J, Klimczak M, Kilanowicz A. The role of zinc in selected female reproductive system disorders. Nutrients 2020;12(8):2464.","DOI":"10.3390\/nu12082464"},{"key":"2158_CR56","doi-asserted-by":"crossref","unstructured":"Vickram S, Rohini K, Srinivasan S, Nancy Veenakumari D, Archana K, Anbarasu K, Jeyanthi P, Thanigaivel S, Gulothungan G, Rajendiran N, et al. Role of zinc (Zn) in human reproduction: a journey from initial spermatogenesis to childbirth. Int J Mol Sci 2021;22(4):2188.","DOI":"10.3390\/ijms22042188"},{"issue":"1","key":"2158_CR57","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12958-022-00982-7","volume":"20","author":"M Jaripur","year":"2022","unstructured":"Jaripur M, Ghasemi-Tehrani H, Askari G, Gholizadeh-Moghaddam M, Clark CCT, Rouhani MH. The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial. Reprod Biol Endocrinol. 2022;20(1):110.","journal-title":"Reprod Biol Endocrinol"},{"key":"2158_CR58","doi-asserted-by":"publisher","first-page":"e16410","DOI":"10.7717\/peerj.16410","volume":"11","author":"X Hu","year":"2023","unstructured":"Hu X, Wang W, Su X, Peng H, Tan Z, Li Y, Huang Y. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis. PeerJ. 2023;11:e16410.","journal-title":"PeerJ"},{"issue":"3","key":"2158_CR59","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.3390\/molecules18033292","volume":"18","author":"Y Mehdi","year":"2013","unstructured":"Mehdi Y, Hornick J-L, Istasse L, Dufrasne I. Selenium in the environment, metabolism and involvement in body functions. Molecules. 2013;18(3):3292\u2013311.","journal-title":"Molecules"},{"issue":"2","key":"2158_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/jn\/136.2.415","volume":"136","author":"ZQ Wang","year":"2006","unstructured":"Wang ZQ, Zhang XH, Russell JC, Hulver M, Cefalu WT. Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. J Nutr. 2006;136(2):415\u201320.","journal-title":"J Nutr"},{"key":"2158_CR61","doi-asserted-by":"crossref","unstructured":"Xu L, Yang Q, Zhou J. Mechanisms of abnormal lipid metabolism in the pathogenesis of disease. Int J Mol Sci 2024;25(15):8465.","DOI":"10.3390\/ijms25158465"},{"issue":"4","key":"2158_CR62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/CRD.0000000000000003","volume":"22","author":"D Kolte","year":"2014","unstructured":"Kolte D, Vijayaraghavan K, Khera S, Sica DA, Frishman WH. Role of magnesium in cardiovascular diseases. Cardiol Rev. 2014;22(4):182\u201392.","journal-title":"Cardiol Rev"},{"issue":"1","key":"2158_CR63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12576-017-0571-7","volume":"68","author":"J Olechnowicz","year":"2018","unstructured":"Olechnowicz J, Tinkov A, Skalny A, Suliburska J. Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism. J Physiol Sci. 2018;68(1):19\u201331.","journal-title":"J Physiol Sci"},{"key":"2158_CR64","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jtemb.2019.01.002","volume":"52","author":"M Abedini","year":"2019","unstructured":"Abedini M, Ghaedi E, Hadi A, Mohammadi H, Amani R. Zinc status and polycystic ovarian syndrome: A systematic review and meta-analysis. J Trace Elem Med Biol. 2019;52:216\u201321.","journal-title":"J Trace Elem Med Biol"},{"issue":"12","key":"2158_CR65","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11892-018-1101-6","volume":"18","author":"P Bjornstad","year":"2018","unstructured":"Bjornstad P, Eckel RH. Pathogenesis of lipid disorders in insulin resistance: a brief review. Curr Diab Rep. 2018;18(12):127.","journal-title":"Curr Diab Rep"},{"key":"2158_CR66","doi-asserted-by":"crossref","unstructured":"Pelczy\u0144ska M, Moszak M, Bogda\u0144ski P. The role of magnesium in the pathogenesis of metabolic disorders. Nutrients 2022;14(9):1714.","DOI":"10.3390\/nu14091714"},{"issue":"21","key":"2158_CR67","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1080\/10408398.2020.1803200","volume":"61","author":"A Kuria","year":"2021","unstructured":"Kuria A, Tian H, Li M, Wang Y, Aaseth JO, Zang J, Cao Y. Selenium status in the body and cardiovascular disease: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2021;61(21):3616\u201325.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2158_CR68","doi-asserted-by":"crossref","unstructured":"Story MJ. Essential sufficiency of zinc, \u03c9-3 polyunsaturated fatty acids, vitamin D and magnesium for prevention and treatment of COVID-19, diabetes, cardiovascular diseases, lung diseases and cancer. Biochimie 2021;187:94\u2013109.","DOI":"10.1016\/j.biochi.2021.05.013"},{"issue":"10","key":"2158_CR69","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1055\/s-2007-985847","volume":"39","author":"M Hummel","year":"2007","unstructured":"Hummel M, Standl E, Schnell O. Chromium in metabolic and cardiovascular disease. Horm Metab Res. 2007;39(10):743\u201351.","journal-title":"Horm Metab Res"},{"key":"2158_CR70","doi-asserted-by":"publisher","first-page":"127338","DOI":"10.1016\/j.jtemb.2023.127338","volume":"81","author":"M Vajdi","year":"2024","unstructured":"Vajdi M, Khajeh M, Safaei E, Moeinolsadat S, Mousavi S, Seyedhosseini-Ghaheh H, Abbasalizad-Farhangi M, Askari G. Effects of chromium supplementation on body composition in patients with type 2 diabetes: A dose-response systematic review and meta-analysis of randomized controlled trials. J Trace Elem Med Biol. 2024;81:127338.","journal-title":"J Trace Elem Med Biol"},{"issue":"12","key":"2158_CR71","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10653-024-02297-5","volume":"46","author":"M-N Georgaki","year":"2024","unstructured":"Georgaki M-N, Tsokkou S, Keramas A, Papamitsou T, Karachrysafi S, Kazakis N. Chromium supplementation and type 2 diabetes mellitus: an extensive systematic review. Environ Geochem Health. 2024;46(12):515.","journal-title":"Environ Geochem Health"},{"issue":"6","key":"2158_CR72","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1089\/dia.2006.8.677","volume":"8","author":"CL Broadhurst","year":"2006","unstructured":"Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus\u2013a review. Diabetes Technol Ther. 2006;8(6):677\u201387.","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"2158_CR73","doi-asserted-by":"publisher","first-page":"e12313","DOI":"10.1111\/cob.12313","volume":"9","author":"C Tsang","year":"2019","unstructured":"Tsang C, Taghizadeh M, Aghabagheri E, Asemi Z, Jafarnejad S. A meta-analysis of the effect of chromium supplementation on anthropometric indices of subjects with overweight or obesity. Clin Obes. 2019;9(4):e12313.","journal-title":"Clin Obes"},{"issue":"8","key":"2158_CR74","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1007\/s12011-022-03474-2","volume":"201","author":"M Vajdi","year":"2022","unstructured":"Vajdi M, Musazadeh V, Karimi A, Heidari H, Tarrahi MJ, Askari G. Effects of chromium supplementation on lipid profile: an umbrella of systematic review and Meta-analysis. Biol Trace Elem Res. 2022;201(8):3658\u201369.","journal-title":"Biol Trace Elem Res"},{"key":"2158_CR75","doi-asserted-by":"publisher","first-page":"1456571","DOI":"10.3389\/fendo.2024.1456571","volume":"15","author":"Y Han","year":"2024","unstructured":"Han Y, Hou Y, Han Q, Yuan X, Chen L. Dietary supplements in polycystic ovary syndrome-current evidence. Front Endocrinol (Lausanne). 2024;15:1456571.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2158_CR76","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.maturitas.2020.05.020","volume":"140","author":"A Capozzi","year":"2020","unstructured":"Capozzi A, Scambia G, Lello S. Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health. Maturitas. 2020;140:55\u201363.","journal-title":"Maturitas"},{"issue":"1","key":"2158_CR77","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s41043-023-00450-x","volume":"42","author":"F Amirkhizi","year":"2023","unstructured":"Amirkhizi F, Hamedi-Shahraki S, Rahimlou M. Dietary total antioxidant capacity is associated with lower disease severity and inflammatory and oxidative stress biomarkers in patients with knee osteoarthritis. J Health Popul Nutr. 2023;42(1):104.","journal-title":"J Health Popul Nutr"},{"issue":"1","key":"2158_CR78","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12011-018-1602-9","volume":"191","author":"M Shokrpour","year":"2018","unstructured":"Shokrpour M, Asemi Z. The effects of magnesium and vitamin E Co-Supplementation on hormonal status and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. Biol Trace Elem Res. 2018;191(1):54\u201360.","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"2158_CR79","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12011-015-0480-7","volume":"170","author":"M Jamilian","year":"2015","unstructured":"Jamilian M, Foroozanfard F, Bahmani F, Talaee R, Monavari M, Asemi Z. Effects of zinc supplementation on endocrine outcomes in women with polycystic ovary syndrome: a Randomized, Double-Blind, Placebo-Controlled trial. Biol Trace Elem Res. 2015;170(2):271\u201378.","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"2158_CR80","first-page":"185","volume":"48","author":"M Razavi","year":"2015","unstructured":"Razavi M, Jamilian M, Kashan ZF, Heidar Z, Mohseni M, Ghandi Y, Bagherian T, Asemi Z. Selenium supplementation and the effects on reproductive Outcomes, biomarkers of Inflammation, and oxidative stress in women with polycystic ovary syndrome. Horm Metab Res. 2015;48(3):185\u201390.","journal-title":"Horm Metab Res"},{"issue":"3","key":"2158_CR81","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1055\/s-0044-101835","volume":"50","author":"J Heshmati","year":"2018","unstructured":"Heshmati J, Omani-Samani R, Vesali S, Maroufizadeh S, Rezaeinejad M, Razavi M, Sepidarkish M. The effects of supplementation with chromium on insulin resistance indices in women with polycystic ovarian syndrome: A systematic review and Meta-Analysis of randomized clinical trials. Horm Metab Res. 2018;50(3):193\u2013200.","journal-title":"Horm Metab Res"},{"issue":"5","key":"2158_CR82","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/biolre\/ioaa131","volume":"103","author":"M Ghasemi","year":"2020","unstructured":"Ghasemi M, Heidari Nia M, Hashemi M, Keikha N, Fazeli K, Taji O, Naghavi A. An association study of polymorphisms in the H19 imprinted gene in an Iranian population with the risk of polycystic ovary syndrome. Biol Reprod. 2020;103(5):978\u201385.","journal-title":"Biol Reprod"},{"issue":"5","key":"2158_CR83","doi-asserted-by":"publisher","first-page":"e25021","DOI":"10.1002\/jcla.25021","volume":"38","author":"F Govahi Kakhki","year":"2024","unstructured":"Govahi Kakhki F, Sargazi S, Montazerifar F, Majidpour M, Karajibani A, Karajibani M, Ghasemi M. IGF2BP2 and IGFBP3 Genotypes, Haplotypes, and genetic models studies in polycystic ovary syndrome. J Clin Lab Anal. 2024;38(5):e25021.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"2158_CR84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12905-025-03553-1","volume":"25","author":"MB Ghalehzan","year":"2025","unstructured":"Ghalehzan MB, Afrasiabi A, Daneshmand F, Ali-Hassanzadeh M, Gharesi-Fard B, Majidi Z. Polymorphism of the insulin resistin (RETN) gene in susceptibility to polycystic ovary syndrome (PCOS) in an Iranian population. BMC Womens Health. 2025;25(1):63.","journal-title":"BMC Womens Health"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02158-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02158-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02158-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:07:24Z","timestamp":1772582844000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-025-02158-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2158"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02158-x","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}